- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2016
- Public Summary Document (PSD) March 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2016 PBAC Meeting - Word
Olaparib – March 2016
Olaparib: 50 mg capsule, 4 x 112, Lynparza®
Last updated
15 July 2016